Transcat Acquires Southeastern Biomedical Associates for $12.8 Million to Expand Biomedical Calibration Services
Transcat, Inc., a provider of accredited calibration services and test and measurement equipment, has announced the acquisition of privately held Southeastern Biomedical Associates Incorporated, a move designed to strengthen the company’s presence in the healthcare and life sciences markets. The transaction became effective on August 31, 2026, and expands Transcat’s capabilities, geographic reach and customer base within the biomedical services sector.
Transcat paid $12.8 million in cash for Southeastern Biomedical Associates, with the final purchase price subject to customary adjustments and holdback provisions. The acquisition forms part of Transcat’s broader strategy of expanding its scale in highly regulated industries where accurate calibration, equipment reliability and regulatory compliance are critical to customer operations and, in healthcare settings, patient safety.
Southeastern Biomedical Associates, commonly known as Southeastern, was established in 1996 and is headquartered in Granite Falls, North Carolina. For more than three decades, the company has provided specialized biomedical equipment services to hospital networks and healthcare facilities across the southeastern United States and other markets.
Its service portfolio includes calibration, equipment repair, preventive maintenance, electrical safety inspections, documentation and regulatory compliance services. Southeastern operates in accordance with ISO/IEC 17025 and ISO 9001 standards, supporting healthcare customers that require reliable equipment performance and documented compliance with applicable quality and regulatory requirements.
In addition to its service activities, Southeastern sells biomedical equipment, patient-ready accessories and equipment parts. The company also assists healthcare organizations with equipment acquisition and asset liquidation, giving customers access to a broader range of services throughout the lifecycle of biomedical equipment.
Strengthening Transcat’s Biomedical Business
The acquisition is expected to complement Transcat’s existing Biomedical business by adding capabilities and extending its geographic presence. Southeastern’s established relationships with hospitals and healthcare facilities in the southeastern United States provide Transcat with an opportunity to expand its customer reach in a market where equipment calibration, maintenance and compliance services are increasingly important.
Healthcare facilities rely on a wide range of biomedical equipment to support patient care, diagnostics, monitoring and other clinical activities. Maintaining these systems requires regular inspection, preventive maintenance and calibration to ensure that equipment performs according to established specifications.
For hospital networks operating across multiple locations, managing equipment maintenance and calibration can also present logistical and compliance challenges. Service providers with broad geographic coverage and standardized quality systems can help healthcare organizations maintain consistent processes across their facilities.
Transcat believes the combination of its existing infrastructure with Southeastern’s regional expertise will allow the company to serve a larger customer base while maintaining its focus on quality, responsiveness and accredited services.
The transaction also supports Transcat’s strategy of building scale in regulated and high-cost-of-failure markets. In these environments, equipment failures or inaccurate measurements can have significant operational, financial or safety consequences. Accredited calibration therefore represents an important component of quality management and regulatory compliance.
Expanding Life Sciences and Healthcare Presence
Transcat President and Chief Executive Officer Jaime Irick said the Southeastern acquisition reinforces the company’s objective of increasing its presence in the life sciences sector.
Irick highlighted Southeastern’s reputation for quality and customer-focused service as important factors behind the transaction. Southeastern has developed long-standing relationships with hospital networks throughout the southeastern region of the U.S. and beyond, creating a foundation that Transcat can build upon as it expands its biomedical operations.
The acquisition also allows Transcat to increase the geographic coverage available to healthcare customers. The company currently operates more than 30 calibration laboratories across North and Central America, giving it an established platform for serving customers that require accredited calibration across multiple locations.
For hospital networks and other regulated organizations, having access to a consistent service provider can be particularly valuable when equipment is distributed across different facilities. A broader service footprint can potentially improve coordination, reduce service complexity and support more consistent calibration and maintenance processes.
Irick also welcomed Southeastern’s employees to Transcat, emphasizing that the company’s existing culture and reputation align with Transcat’s own operating principles. According to Transcat, Southeastern has developed a strong internal culture under the leadership of former owners Boyd Campbell and Greg Johnson, together with a commitment to high-quality service and customer satisfaction.
Southeastern Brings Long-Term Customer Relationships
Southeastern Biomedical’s history in the biomedical services industry dates back to 1996. Over that period, the company has established itself as a service provider for hospitals and healthcare organizations throughout the southeastern United States.
Greg Johnson, co-owner of Southeastern Biomedical, said the company’s more than 30 years of experience have been built around customer satisfaction, service quality and a strong employee culture.
Johnson said Transcat was selected as a partner because of its reputation for supporting acquired employees and customers while maintaining the operating principles that have contributed to the success of the businesses it acquires.
Both Johnson and fellow co-owner Boyd Campbell are expected to join the Transcat organization following the transaction. Their continued involvement is intended to support the integration of Southeastern into Transcat’s Biomedical business while helping preserve the relationships and operational knowledge developed over the company’s history.
Johnson also expressed confidence in the prospects for the combined organization, describing the future of Transcat Biomedical as an opportunity to build on the strengths of both companies.
Focus on Accredited Calibration and Compliance
Accredited calibration is an important component of quality management across numerous industries, particularly where inaccurate measurements or equipment failures could have serious consequences.
In healthcare, biomedical equipment must be properly maintained and monitored to support reliable operation. Hospitals and healthcare networks also face regulatory and documentation requirements that make preventive maintenance, electrical safety inspections, calibration and recordkeeping important elements of their equipment management programs.
Southeastern’s experience in these areas complements Transcat’s broader calibration capabilities. Its compliance-oriented services are designed to help customers maintain equipment and documentation in accordance with applicable quality standards.
By bringing Southeastern into its organization, Transcat can strengthen its ability to provide biomedical services across a larger geographic area while leveraging its existing laboratory network and operational infrastructure.
The company’s more than 30 calibration laboratories across North and Central America provide a significant foundation for supporting customers in regulated markets. The Southeastern transaction adds another layer of regional expertise and service capability to this network.
Acquisition Supports Transcat’s Growth Strategy
The Southeastern transaction is also consistent with Transcat’s broader acquisition strategy. The company has identified M&A as an important tool for expanding its presence in regulated verticals and increasing the scale of its service operations.
Transcat CEO Jaime Irick said acquisitions such as Southeastern Biomedical remain central to the company’s forward strategy. He noted that Southeastern brings strong leadership, an established reputation for quality, a positive workplace culture and experienced employees.
The company expects the combination to create additional opportunities across the combined customer base. By integrating Southeastern’s capabilities with Transcat’s existing resources, the company aims to increase its ability to provide high-quality service while maintaining competitive turnaround times.
The acquisition is particularly relevant as healthcare organizations continue to seek reliable partners capable of managing increasingly complex biomedical equipment fleets. Hospital systems need dependable calibration and maintenance services to support clinical operations while meeting regulatory and quality expectations.
With the acquisition now completed, Transcat will focus on integrating Southeastern Biomedical Associates into its existing Biomedical business. The transaction provides Transcat with additional personnel, customer relationships, service capabilities and geographic coverage in the southeastern United States.
The company expects the acquisition to contribute to its broader fiscal 2027 growth strategy, which includes additional mergers and acquisitions as well as continued improvement in service gross margins.
For Southeastern, joining Transcat provides access to the resources and broader infrastructure of a larger organization while retaining the expertise and customer-focused principles that have helped establish its reputation.
For Transcat, the acquisition strengthens its position in biomedical calibration and expands its reach within the highly regulated healthcare and life sciences sectors. The combination of Southeastern’s regional presence and Transcat’s broader calibration network creates an expanded platform for supporting hospital networks and other regulated customers.
As healthcare providers continue to prioritize equipment reliability, regulatory compliance and efficient asset management, demand for specialized biomedical calibration and maintenance services is expected to remain important. Transcat’s acquisition of Southeastern Biomedical Associates therefore represents a strategic investment in a market closely aligned with its long-term growth objectives.
The $12.8 million transaction not only adds scale to Transcat’s Biomedical business but also reinforces the company’s commitment to serving industries where precision, compliance and equipment reliability are essential. With the two organizations now combined, Transcat aims to build on Southeastern’s established customer relationships and service expertise while leveraging its own infrastructure to pursue continued growth across the biomedical and life sciences markets.
About Southeastern Biomedical Associates
Founded in 1996 and headquartered in Granite Falls, North Carolina, Southeastern Biomedical Associates provides repair service, preventive maintenance, calibration, electrical safety inspection, complete documentation and regulatory compliance that helps medical facilities of all types deliver efficient, cost-effective, quality medical technology management.
Southeastern’s mission is to provide healthcare facilities with a viable option to acquire and maintain medical equipment in a cost-effective manner, while delivering superior quality. Southeastern’s customers include hospitals, ambulatory surgical centers, clinics, physician offices, home care dealers, and EMS. More information about Southeastern Biomedical can be found at sebiomedical.com.
About Transcat
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities.
Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its Calibration Service Centers strategically located across the United States and Internationally. In addition, Transcat operates calibration labs in imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, Cost, Control and Optimizations services, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at Transcat.com.